iHuman Inc. (IH) P/E Ratio History
ExpensiveTrading at 1.0x vs 5Y avg 0.4x · 91th percentile · Material premium to history · Data 2022–2025
Loading P/E history...
P/E Ratio Analysis
As of June 22, 2026, iHuman Inc. (IH) trades at a price-to-earnings ratio of 1.0x, with a stock price of $1.38 and trailing twelve-month earnings per share of $10.29.
The current P/E is 176% above its 5-year average of 0.4x. Over the past five years, IH's P/E has ranged from a low of 0.1x to a high of 2.1x, placing the current valuation at the 91th percentile of its historical range.
Compared to the Consumer Defensive sector median P/E of 18.8x, IH trades at a 94% discount to its sector peers. The sector includes 151 companies with P/E ratios ranging from 0.0x to 193.7x.
Relative to the broader market, IH trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our IH DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
IH Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
IH P/E vs Peers
Consumer Learning Platforms and Apps peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $621M | 7.3Lowest | - | +2473%Best | |
| $7B | 19.6 | - | +28% | |
| $1B | 90.6 | - | +29% | |
| $2M | 17.6 | - | -82% | |
| $7B | 44.9 | - | +180% | |
| $38B | 64.3 | - | -82% | |
| $77B | 15.7 | 0.66Best | +14% | |
| $6B | 14.7 | - | +356% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
IH Historical P/E Data (2022–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q2 | Jun 30 2025 | $2.50 | $10.20 | 0.2x | -35% |
| FY2025 Q1 | Mar 31 2025 | $2.12 | $9.50 | 0.2x | -41% |
| FY2024 Q4 | - | $1.69 | $9.10 | 0.2x | -51% |
| FY2024 Q3 | Sep 30 2024 | $2.30 | $9.60 | 0.2x | -36% |
| FY2024 Q2 | Jun 30 2024 | $1.79 | $12.13 | 0.1x | -61% |
| FY2024 Q1 | Mar 31 2024 | $1.70 | $13.80 | 0.1x | -67% |
| FY2023 Q4 | Dec 31 2023 | $3.07 | $16.74 | 0.2x | -51% |
| FY2023 Q3 | Sep 30 2023 | $3.02 | $16.90 | 0.2x | -52% |
| FY2023 Q2 | Jun 30 2023 | $2.96 | $15.92 | 0.2x | -51% |
| FY2023 Q1 | Mar 31 2023 | $3.24 | $11.21 | 0.3x | -23% |
| FY2022 Q4 | Dec 31 2022 | $2.60 | $1.22 | 2.1x | +467% |
Average P/E for displayed period: 0.4x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
4+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
IH — Frequently Asked Questions
Quick answers to the most common questions about buying IH stock.
What is IH's P/E ratio?
iHuman Inc. (IH) trailing twelve-month P/E ratio is 1.0x, based on TTM diluted EPS of $10.29. The 5-year average P/E is 0.4x and the historical range spans 0.1x to 2.1x.
Is IH stock overvalued or undervalued?
IH trades at 1.0x P/E, above its 5-year average of 0.4x. The 91th percentile ranking within the 0.1x–2.1x historical range indicates a premium to historical valuation.
Is IH stock expensive?
Yes, IH is expensive relative to its own history. The current P/E of 1.0x is above the 5-year average of 0.4x. The stock sits at the 91th percentile of its 5-year valuation range.
What is IH's historical P/E range?
Over the past 5 years, IH's P/E ratio has ranged from 0.1x to 2.1x, with a median of 0.2x and an average of 0.4x. The current P/E of 1.0x places the stock at the 91th percentile of this range. Full historical data spans 2022–2025.
How does IH's P/E compare to the S&P 500?
IH trades at 1.0x P/E versus the S&P 500 median of 24.4x. The 96% discount to the market suggests lower growth expectations or perceived higher risk.
How does IH's valuation compare to Consumer Defensive peers?
iHuman Inc. P/E of 1.0x compares to the Consumer Defensive sector median of 18.8x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is IH's PEG ratio?
IH PEG ratio is N/A, based on a P/E of 1.0x and EPS growth of -45.5%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is IH's earnings yield?
IH earnings yield is 96.50%, the inverse of its 1.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.